Dritte Verordnung zur Änderung der Betriebsverordnung für pharmazeutische Unternehmer vom 10 August 2004

This procedure involves updating the operational regulations for pharmaceutical companies in Germany. It aims to refine the legal requirements and standards that manufacturers and distributors must follow to ensure the safety and quality of medicinal products. The changes primarily affect pharmaceutical companies and industry professionals, ensuring they comply with updated manufacturing and distribution standards within the German healthcare market.